+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Calcitonin secretion in postmenopausal osteoporosis



Calcitonin secretion in postmenopausal osteoporosis



New England Journal of Medicine 312(17): 1097-1100



Calcitonin deficiency has been implicated in the pathogenesis of accelerated bone loss, especially in postmenopausal osteoporosis. To investigate this issue, we studied 25 patients with untreated postmenopausal osteoporosis, 14 age-matched and sex-matched healthy controls (spinal bone mineral density greater than or equal to age-specific and sex-specific mean), and 5 women who had undergone total thyroidectomy. Each subject received an intravenous infusion of 2 mg of elemental calcium per kilogram of body weight over 5 minutes, to test the C-cell secretory reserve. We measured calcitonin by radioimmunoassay in whole plasma and in silica-cartridge extracts of plasma, the latter method providing greatly improved sensitivity and specificity for monomeric calcitonin. Basal immunoreactive calcitonin concentrations, whether measured in whole plasma or in extracts, were significantly higher in the subjects with osteoporosis (P less than 0.01) than in the healthy controls. The calcitonin secretory reserve, as assessed by calcium stimulation, was normal in the osteoporotic group but virtually absent in the thyroidectomy group. We conclude that postmenopausal osteoporosis is not associated with and does not result from calcitonin deficiency. On the contrary, excessive skeletal calcium release may stimulate calcitonin secretion in patients with the disorder.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 001311491

Download citation: RISBibTeXText

PMID: 3982469

DOI: 10.1056/NEJM198504253121705


Related references

Effects in postmenopausal women of natural and synthetic estrogens on calcitonin and calcium-regulating hormone secretion. Relevance to postmenopausal osteoporosis. Acta Obstetricia et Gynecologica Scandinavica. Supplement 106: 27-32, 1981

Calcitonin secretion and postmenopausal osteoporosis. Lancet 1(8275): 804, 1982

Role of endogenous calcitonin secretion in postmenopausal osteoporosis. Revue Medicale de Bruxelles Nouvelle Serie 8(6-7): 325-328, 1987

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocrine Reviews 23(4): 540-551, 2002

Treatment of postmenopausal osteoporosis with low doses of calcitonin and a calcitonin-anabolic combination. Orvosi Hetilap 133(23): 1415-1418, 1992

Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. American Journal of Medicine 117(8): 549-555, 2004

Osteoblast numbers after calcitonin therapy: a retrospective study of paired biopsies obtained during long-term calcitonin therapy in postmenopausal osteoporosis. Calcified Tissue International 66(1): 29-34, 1999

Calcitonin and postmenopausal osteoporosis. Clinical Endocrinology 20(1): 85-92, 1984

Rationale for the use of calcitonin in postmenopausal osteoporosis. Annales Chirurgiae et Gynaecologiae 77(5-6): 224-228, 1988

Eel calcitonin in the prophylaxis of postmenopausal osteoporosis. Genazzani, A R , F Petraglia And A Volpe (Ed ) Progress in Gynecology And Obstetrics; Second European Winter Conference in Gynecology And Obstetrics, Madonna Di Campiglio, Italy, March 1989 Xxvi+944p Parthenon Publishing Group: Carnforth, England, Uk; Park Ridge, New Jersey, Usa Illus 833-838, 1990

Synthetic calcitonin for postmenopausal osteoporosis. Medical Letter on Drugs and Therapeutics 27(690): 53-54, 1985

Etidronate and calcitonin to PTH (1-84) in postmenopausal osteoporosis. Anales de la Real Academia Nacional de Medicina 128(1): 169-91; Discussion 191-8, 2013

Prevention of postmenopausal osteoporosis by calcitonin. European Journal of Clinical Investigation 19(2 PART 2): A87, 1989

Calcitonin deficiency in postmenopausal osteoporosis. Medicina Clinica 85(6): 221-224, 1985

Role of endogenous calcitonin in postmenopausal osteoporosis. Revue Medicale de Bruxelles 8(6-7): 325-328, 1987